FEDEX CORP · News & developments
IWP Capital Pushes for Board Review of Abortion Drug Delivery Risks at FedEx
Faith-based service provider IWP Capital announced it will vote in favor of Proposal 6 at FedEx's annual meeting on September 28, 2026. Co-filed with the Catholic Diocese of Fort Worth, the precatory resolution asks the board to issue a report within one year assessing oversight of legal, regulatory, and reputational risks tied to shipping mail-order abortion medications like mifepristone.
Why this matters
Common carriers operate on thin ground when federal and state regulatory directives collide. While the resolution does not ask FedEx to halt shipments or inspect parcels, it attempts to force corporate governance disclosures regarding exposure under unsettled statutes such as the Comstock Act. Because the measure is non-binding and advisory, it creates no immediate operational liability or volume interruption for FedEx's delivery network, though the vote tally will measure how much governance pressure institutional holders want to apply on polarizing distribution questions.